[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fzPIzduGhFuAYq5EhvH6XK1HdKKsT0emV2t2WMUVvwlM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":64,"rows":71},"Medical University of Bialystok",[4],65,false,19,2,8490381,7,46,[14,17,20,23,25,27,29,31],{"name":15,"count":16},"Obesity",11,{"name":18,"count":19},"PreDiabetes",4,{"name":21,"count":22},"Glaucoma",3,{"name":24,"count":22},"Acute Coronary Syndrome",{"name":26,"count":22},"Coronary Artery Disease",{"name":28,"count":9},"Particulate Matter Inhalation Injury",{"name":30,"count":9},"Pollution; Exposure",{"name":32,"count":9},"Diabetes",[34,39,44,49,54,59],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06920849","Evaluation of the Influence of PRF (Platelet-rich Fibrin) on the Clinical Parameters and the Concentration of Selected Inflammation Mediators in GCF (Gingival Crevice Fluid) of Patients With Periodontitis","2025-06-30","SRP+iPRF",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT07027137","The Influence of Local Antibiotic Therapy on the Outcomes Following Periodontal Regeneration Procedures.","2025-12-30","SRP+ANB+SURG",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT05340868","Genetics of the Acute Response to Oral Semaglutide","2025-12-31","Semaglutide Pill",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT05467033","Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin","2026-08-31","Desmopressin",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT04789057","Atorvastatin Effect on Reduction of COPD Exacerbations","2026-12-31","Atorvastatin 40 Mg Oral",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT06012682","Clinical Trials Evaluating the Effect of Metformin Treatment on Function Endometrium in Women Diagnosed With Idiopathic Infertility","2027-09-30","Metformin Hydrochloride",[65,66,67,68,69,70],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[72,101,124,142,164,186,206,226,256,283,301,319,344,370,399,417,435,453,479,505,537,555,573,591,609,627,654,672,698,716,742,760,787,805,831],{"intervention":58,"totalTrials":73,"cells":74},1,{"EARLY_PHASE1":75,"PHASE1":78,"PHASE2":80,"PHASE3":82,"PHASE4":84,"NA":99},{"trials":76,"activeCount":77},[],0,{"trials":79,"activeCount":77},[],{"trials":81,"activeCount":77},[],{"trials":83,"activeCount":77},[],{"trials":85,"activeCount":73,"soonestReadout":57},[86],{"nctId":55,"briefTitle":56,"status":87,"phases":88,"primaryCompletion":57,"completion":89,"start":90,"enrollment":91,"conditions":92,"interventions":98},"ACTIVE_NOT_RECRUITING",[69],"2027-05-31","2022-02-11",460,[93,94,95,96,97],"Copd","COPD Exacerbation","Smoking","Gene Expression","Atorvastatin",[58],{"trials":100,"activeCount":77},[],{"intervention":53,"totalTrials":73,"cells":102},{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":107,"PHASE3":109,"PHASE4":120,"NA":122},{"trials":104,"activeCount":77},[],{"trials":106,"activeCount":77},[],{"trials":108,"activeCount":77},[],{"trials":110,"activeCount":73,"soonestReadout":52},[111],{"nctId":50,"briefTitle":51,"status":112,"phases":113,"primaryCompletion":52,"completion":52,"start":114,"enrollment":115,"conditions":116,"interventions":118},"RECRUITING",[68],"2022-09-01",424,[117],"Kidney Biopsy",[53,119],"intravenous infusion NaCl",{"trials":121,"activeCount":77},[],{"trials":123,"activeCount":77},[],{"intervention":119,"totalTrials":73,"cells":125},{"EARLY_PHASE1":126,"PHASE1":128,"PHASE2":130,"PHASE3":132,"PHASE4":138,"NA":140},{"trials":127,"activeCount":77},[],{"trials":129,"activeCount":77},[],{"trials":131,"activeCount":77},[],{"trials":133,"activeCount":73,"soonestReadout":52},[134],{"nctId":50,"briefTitle":51,"status":112,"phases":135,"primaryCompletion":52,"completion":52,"start":114,"enrollment":115,"conditions":136,"interventions":137},[68],[117],[53,119],{"trials":139,"activeCount":77},[],{"trials":141,"activeCount":77},[],{"intervention":63,"totalTrials":73,"cells":143},{"EARLY_PHASE1":144,"PHASE1":146,"PHASE2":148,"PHASE3":158,"PHASE4":160,"NA":162},{"trials":145,"activeCount":77},[],{"trials":147,"activeCount":77},[],{"trials":149,"activeCount":73,"soonestReadout":62},[150],{"nctId":60,"briefTitle":61,"status":151,"phases":152,"primaryCompletion":62,"completion":62,"start":153,"enrollment":154,"conditions":155,"interventions":157},"NOT_YET_RECRUITING",[67],"2023-08-30",200,[156],"Infertility, Female",[63],{"trials":159,"activeCount":77},[],{"trials":161,"activeCount":77},[],{"trials":163,"activeCount":77},[],{"intervention":43,"totalTrials":73,"cells":165},{"EARLY_PHASE1":166,"PHASE1":168,"PHASE2":170,"PHASE3":172,"PHASE4":174,"NA":176},{"trials":167,"activeCount":77},[],{"trials":169,"activeCount":77},[],{"trials":171,"activeCount":77},[],{"trials":173,"activeCount":77},[],{"trials":175,"activeCount":77},[],{"trials":177,"activeCount":73,"soonestReadout":42},[178],{"nctId":40,"briefTitle":41,"status":87,"phases":179,"primaryCompletion":42,"completion":42,"start":180,"enrollment":181,"conditions":182,"interventions":185},[70],"2019-08-01",40,[183,184],"Periodontitis","Periodontal Diseases",[43],{"intervention":48,"totalTrials":73,"cells":187},{"EARLY_PHASE1":188,"PHASE1":190,"PHASE2":192,"PHASE3":194,"PHASE4":196,"NA":198},{"trials":189,"activeCount":77},[],{"trials":191,"activeCount":77},[],{"trials":193,"activeCount":77},[],{"trials":195,"activeCount":77},[],{"trials":197,"activeCount":77},[],{"trials":199,"activeCount":73,"soonestReadout":47},[200],{"nctId":45,"briefTitle":46,"status":112,"phases":201,"primaryCompletion":47,"completion":47,"start":114,"enrollment":202,"conditions":203,"interventions":205},[70],1000,[18,204,15],"Prediabetic State",[48],{"intervention":38,"totalTrials":73,"cells":207},{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":214,"PHASE4":216,"NA":218},{"trials":209,"activeCount":77},[],{"trials":211,"activeCount":77},[],{"trials":213,"activeCount":77},[],{"trials":215,"activeCount":77},[],{"trials":217,"activeCount":77},[],{"trials":219,"activeCount":73,"soonestReadout":37},[220],{"nctId":35,"briefTitle":36,"status":87,"phases":221,"primaryCompletion":37,"completion":37,"start":222,"enrollment":181,"conditions":223,"interventions":225},[70],"2022-04-01",[224,183],"Periodontal Disease",[38],{"intervention":227,"totalTrials":73,"cells":228},"Levosimendan",{"EARLY_PHASE1":229,"PHASE1":231,"PHASE2":233,"PHASE3":235,"PHASE4":237,"NA":254},{"trials":230,"activeCount":77},[],{"trials":232,"activeCount":77},[],{"trials":234,"activeCount":77},[],{"trials":236,"activeCount":77},[],{"trials":238,"activeCount":77},[239],{"nctId":240,"briefTitle":241,"status":242,"phases":243,"primaryCompletion":244,"completion":245,"start":246,"enrollment":247,"conditions":248,"interventions":253},"NCT04705337","Levosimendan In Ambulatory Heart Failure Patients","TERMINATED",[69],"2024-02-29","2024-08-15","2021-12-15",70,[249,250,251,252],"Heart Failure New York Heart Association Class III","Heart Failure New York Heart Association Class IV","Heart Failure, Systolic","Heart Failure With Reduced Ejection Fraction",[227],{"trials":255,"activeCount":77},[],{"intervention":97,"totalTrials":73,"cells":257},{"EARLY_PHASE1":258,"PHASE1":260,"PHASE2":262,"PHASE3":264,"PHASE4":266,"NA":281},{"trials":259,"activeCount":77},[],{"trials":261,"activeCount":77},[],{"trials":263,"activeCount":77},[],{"trials":265,"activeCount":77},[],{"trials":267,"activeCount":77},[268],{"nctId":269,"briefTitle":270,"status":271,"phases":272,"primaryCompletion":273,"completion":273,"start":274,"enrollment":275,"conditions":276,"interventions":278},"NCT01748279","The Effects of Atorvastatin Treatment in COPD Patients","COMPLETED",[69],"2013-04","2012-12",18,[277],"COPD",[97,279,280],"Formoterol","Lactose",{"trials":282,"activeCount":77},[],{"intervention":279,"totalTrials":73,"cells":284},{"EARLY_PHASE1":285,"PHASE1":287,"PHASE2":289,"PHASE3":291,"PHASE4":293,"NA":299},{"trials":286,"activeCount":77},[],{"trials":288,"activeCount":77},[],{"trials":290,"activeCount":77},[],{"trials":292,"activeCount":77},[],{"trials":294,"activeCount":77},[295],{"nctId":269,"briefTitle":270,"status":271,"phases":296,"primaryCompletion":273,"completion":273,"start":274,"enrollment":275,"conditions":297,"interventions":298},[69],[277],[97,279,280],{"trials":300,"activeCount":77},[],{"intervention":280,"totalTrials":73,"cells":302},{"EARLY_PHASE1":303,"PHASE1":305,"PHASE2":307,"PHASE3":309,"PHASE4":311,"NA":317},{"trials":304,"activeCount":77},[],{"trials":306,"activeCount":77},[],{"trials":308,"activeCount":77},[],{"trials":310,"activeCount":77},[],{"trials":312,"activeCount":77},[313],{"nctId":269,"briefTitle":270,"status":271,"phases":314,"primaryCompletion":273,"completion":273,"start":274,"enrollment":275,"conditions":315,"interventions":316},[69],[277],[97,279,280],{"trials":318,"activeCount":77},[],{"intervention":320,"totalTrials":73,"cells":321},"Omeprazole",{"EARLY_PHASE1":322,"PHASE1":324,"PHASE2":326,"PHASE3":328,"PHASE4":330,"NA":342},{"trials":323,"activeCount":77},[],{"trials":325,"activeCount":77},[],{"trials":327,"activeCount":77},[],{"trials":329,"activeCount":77},[],{"trials":331,"activeCount":77},[332],{"nctId":333,"briefTitle":334,"status":271,"phases":335,"primaryCompletion":336,"completion":336,"start":337,"enrollment":338,"conditions":339,"interventions":341},"NCT03980496","Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding",[69],"2013-06-08","2010-09-09",50,[340],"Non-variceal Upper Gastrointestinal Bleeding",[320],{"trials":343,"activeCount":77},[],{"intervention":345,"totalTrials":73,"cells":346},"metformin",{"EARLY_PHASE1":347,"PHASE1":349,"PHASE2":351,"PHASE3":353,"PHASE4":366,"NA":368},{"trials":348,"activeCount":77},[],{"trials":350,"activeCount":77},[],{"trials":352,"activeCount":77},[],{"trials":354,"activeCount":77},[355],{"nctId":356,"briefTitle":357,"status":358,"phases":359,"primaryCompletion":360,"completion":360,"start":361,"enrollment":362,"conditions":363,"interventions":365},"NCT05468554","Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer","UNKNOWN",[68],"2026-04-30","2022-11-01",160,[364],"Thyroid Cancer",[345],{"trials":367,"activeCount":77},[],{"trials":369,"activeCount":77},[],{"intervention":371,"totalTrials":73,"cells":372},"Lactobacillus Plantarum 299v",{"EARLY_PHASE1":373,"PHASE1":375,"PHASE2":377,"PHASE3":393,"PHASE4":395,"NA":397},{"trials":374,"activeCount":77},[],{"trials":376,"activeCount":77},[],{"trials":378,"activeCount":77},[379],{"nctId":380,"briefTitle":381,"status":271,"phases":382,"primaryCompletion":383,"completion":383,"start":384,"enrollment":385,"conditions":386,"interventions":389},"NCT02469545","Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment",[67],"2016-03","2014-06",60,[387,388],"Depression","Anxiety Disorder",[371,390,391,392],"Crystalline cellulose powder","Escitalopram","Sertraline",{"trials":394,"activeCount":77},[],{"trials":396,"activeCount":77},[],{"trials":398,"activeCount":77},[],{"intervention":390,"totalTrials":73,"cells":400},{"EARLY_PHASE1":401,"PHASE1":403,"PHASE2":405,"PHASE3":411,"PHASE4":413,"NA":415},{"trials":402,"activeCount":77},[],{"trials":404,"activeCount":77},[],{"trials":406,"activeCount":77},[407],{"nctId":380,"briefTitle":381,"status":271,"phases":408,"primaryCompletion":383,"completion":383,"start":384,"enrollment":385,"conditions":409,"interventions":410},[67],[387,388],[371,390,391,392],{"trials":412,"activeCount":77},[],{"trials":414,"activeCount":77},[],{"trials":416,"activeCount":77},[],{"intervention":391,"totalTrials":73,"cells":418},{"EARLY_PHASE1":419,"PHASE1":421,"PHASE2":423,"PHASE3":429,"PHASE4":431,"NA":433},{"trials":420,"activeCount":77},[],{"trials":422,"activeCount":77},[],{"trials":424,"activeCount":77},[425],{"nctId":380,"briefTitle":381,"status":271,"phases":426,"primaryCompletion":383,"completion":383,"start":384,"enrollment":385,"conditions":427,"interventions":428},[67],[387,388],[371,390,391,392],{"trials":430,"activeCount":77},[],{"trials":432,"activeCount":77},[],{"trials":434,"activeCount":77},[],{"intervention":392,"totalTrials":73,"cells":436},{"EARLY_PHASE1":437,"PHASE1":439,"PHASE2":441,"PHASE3":447,"PHASE4":449,"NA":451},{"trials":438,"activeCount":77},[],{"trials":440,"activeCount":77},[],{"trials":442,"activeCount":77},[443],{"nctId":380,"briefTitle":381,"status":271,"phases":444,"primaryCompletion":383,"completion":383,"start":384,"enrollment":385,"conditions":445,"interventions":446},[67],[387,388],[371,390,391,392],{"trials":448,"activeCount":77},[],{"trials":450,"activeCount":77},[],{"trials":452,"activeCount":77},[],{"intervention":454,"totalTrials":73,"cells":455},"Granulocyte colony-stimulating factor",{"EARLY_PHASE1":456,"PHASE1":458,"PHASE2":471,"PHASE3":473,"PHASE4":475,"NA":477},{"trials":457,"activeCount":77},[],{"trials":459,"activeCount":77},[460],{"nctId":461,"briefTitle":462,"status":358,"phases":463,"primaryCompletion":464,"completion":465,"start":466,"enrollment":467,"conditions":468,"interventions":470},"NCT02814110","Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy",[66],"2021-12-31","2022-12-31","2013-03-01",27,[469],"Increase Muscle Strength in Patients With Muscular Dystrophy",[454],{"trials":472,"activeCount":77},[],{"trials":474,"activeCount":77},[],{"trials":476,"activeCount":77},[],{"trials":478,"activeCount":77},[],{"intervention":480,"totalTrials":73,"cells":481},"Empagliflozin",{"EARLY_PHASE1":482,"PHASE1":484,"PHASE2":486,"PHASE3":488,"PHASE4":490,"NA":492},{"trials":483,"activeCount":77},[],{"trials":485,"activeCount":77},[],{"trials":487,"activeCount":77},[],{"trials":489,"activeCount":77},[],{"trials":491,"activeCount":77},[],{"trials":493,"activeCount":77},[494],{"nctId":495,"briefTitle":496,"status":271,"phases":497,"primaryCompletion":498,"completion":498,"start":499,"enrollment":247,"conditions":500,"interventions":504},"NCT07556094","Empagliflozin and CPAP in Adults With Heart Failure and Obstructive Sleep Apnea.",[70],"2025-05-09","2023-06-05",[501,502,503],"Obstructive Sleep Apnea (OSA)","Sleep Apnea Syndrome, Obstructive","Heart Failure",[480],{"intervention":506,"totalTrials":73,"cells":507},"Tiotropium",{"EARLY_PHASE1":508,"PHASE1":510,"PHASE2":512,"PHASE3":514,"PHASE4":516,"NA":518},{"trials":509,"activeCount":77},[],{"trials":511,"activeCount":77},[],{"trials":513,"activeCount":77},[],{"trials":515,"activeCount":77},[],{"trials":517,"activeCount":77},[],{"trials":519,"activeCount":77},[520],{"nctId":521,"briefTitle":522,"status":523,"phases":524,"primaryCompletion":525,"completion":526,"start":527,"enrollment":528,"conditions":529,"interventions":531},"NCT07541378","Comparative Efficacy of Once-daily LAMA\u002FLABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPD","SUSPENDED",[70],"2025-02-07","2027-09-01","2024-03-11",100,[530],"COPD (Chronic Obstructive Pulmonary Disease)",[506,532,533,534,535,536],"Olodaterol","Umeclidinium","Vilanterol","Indacaterol","Glycopyrronium",{"intervention":532,"totalTrials":73,"cells":538},{"EARLY_PHASE1":539,"PHASE1":541,"PHASE2":543,"PHASE3":545,"PHASE4":547,"NA":549},{"trials":540,"activeCount":77},[],{"trials":542,"activeCount":77},[],{"trials":544,"activeCount":77},[],{"trials":546,"activeCount":77},[],{"trials":548,"activeCount":77},[],{"trials":550,"activeCount":77},[551],{"nctId":521,"briefTitle":522,"status":523,"phases":552,"primaryCompletion":525,"completion":526,"start":527,"enrollment":528,"conditions":553,"interventions":554},[70],[530],[506,532,533,534,535,536],{"intervention":533,"totalTrials":73,"cells":556},{"EARLY_PHASE1":557,"PHASE1":559,"PHASE2":561,"PHASE3":563,"PHASE4":565,"NA":567},{"trials":558,"activeCount":77},[],{"trials":560,"activeCount":77},[],{"trials":562,"activeCount":77},[],{"trials":564,"activeCount":77},[],{"trials":566,"activeCount":77},[],{"trials":568,"activeCount":77},[569],{"nctId":521,"briefTitle":522,"status":523,"phases":570,"primaryCompletion":525,"completion":526,"start":527,"enrollment":528,"conditions":571,"interventions":572},[70],[530],[506,532,533,534,535,536],{"intervention":534,"totalTrials":73,"cells":574},{"EARLY_PHASE1":575,"PHASE1":577,"PHASE2":579,"PHASE3":581,"PHASE4":583,"NA":585},{"trials":576,"activeCount":77},[],{"trials":578,"activeCount":77},[],{"trials":580,"activeCount":77},[],{"trials":582,"activeCount":77},[],{"trials":584,"activeCount":77},[],{"trials":586,"activeCount":77},[587],{"nctId":521,"briefTitle":522,"status":523,"phases":588,"primaryCompletion":525,"completion":526,"start":527,"enrollment":528,"conditions":589,"interventions":590},[70],[530],[506,532,533,534,535,536],{"intervention":535,"totalTrials":73,"cells":592},{"EARLY_PHASE1":593,"PHASE1":595,"PHASE2":597,"PHASE3":599,"PHASE4":601,"NA":603},{"trials":594,"activeCount":77},[],{"trials":596,"activeCount":77},[],{"trials":598,"activeCount":77},[],{"trials":600,"activeCount":77},[],{"trials":602,"activeCount":77},[],{"trials":604,"activeCount":77},[605],{"nctId":521,"briefTitle":522,"status":523,"phases":606,"primaryCompletion":525,"completion":526,"start":527,"enrollment":528,"conditions":607,"interventions":608},[70],[530],[506,532,533,534,535,536],{"intervention":536,"totalTrials":73,"cells":610},{"EARLY_PHASE1":611,"PHASE1":613,"PHASE2":615,"PHASE3":617,"PHASE4":619,"NA":621},{"trials":612,"activeCount":77},[],{"trials":614,"activeCount":77},[],{"trials":616,"activeCount":77},[],{"trials":618,"activeCount":77},[],{"trials":620,"activeCount":77},[],{"trials":622,"activeCount":77},[623],{"nctId":521,"briefTitle":522,"status":523,"phases":624,"primaryCompletion":525,"completion":526,"start":527,"enrollment":528,"conditions":625,"interventions":626},[70],[530],[506,532,533,534,535,536],{"intervention":628,"totalTrials":73,"cells":629},"Rocuronium",{"EARLY_PHASE1":630,"PHASE1":632,"PHASE2":634,"PHASE3":636,"PHASE4":638,"NA":640},{"trials":631,"activeCount":77},[],{"trials":633,"activeCount":77},[],{"trials":635,"activeCount":77},[],{"trials":637,"activeCount":77},[],{"trials":639,"activeCount":77},[],{"trials":641,"activeCount":77},[642],{"nctId":643,"briefTitle":644,"status":271,"phases":645,"primaryCompletion":646,"completion":647,"start":648,"enrollment":649,"conditions":650,"interventions":652},"NCT04035707","Serum Tryptase Concentration During General Anaesthesia With Rocuronium",[70],"2010-06-25","2014-05-15","2009-06-25",126,[651],"Hypersensitivity Reaction",[628,653],"general volatile anaesthesia",{"intervention":653,"totalTrials":73,"cells":655},{"EARLY_PHASE1":656,"PHASE1":658,"PHASE2":660,"PHASE3":662,"PHASE4":664,"NA":666},{"trials":657,"activeCount":77},[],{"trials":659,"activeCount":77},[],{"trials":661,"activeCount":77},[],{"trials":663,"activeCount":77},[],{"trials":665,"activeCount":77},[],{"trials":667,"activeCount":77},[668],{"nctId":643,"briefTitle":644,"status":271,"phases":669,"primaryCompletion":646,"completion":647,"start":648,"enrollment":649,"conditions":670,"interventions":671},[70],[651],[628,653],{"intervention":673,"totalTrials":73,"cells":674},"MT-ATP6 mtDNA gene variability in obesity and normal body weight patients.",{"EARLY_PHASE1":675,"PHASE1":677,"PHASE2":679,"PHASE3":681,"PHASE4":683,"NA":685},{"trials":676,"activeCount":77},[],{"trials":678,"activeCount":77},[],{"trials":680,"activeCount":77},[],{"trials":682,"activeCount":77},[],{"trials":684,"activeCount":77},[],{"trials":686,"activeCount":77},[687],{"nctId":688,"briefTitle":689,"status":271,"phases":690,"primaryCompletion":691,"completion":691,"start":692,"enrollment":693,"conditions":694,"interventions":696},"NCT05789888","Genes Variability in Obesity and Normal Body Weight Patients.",[],"2023-01-01","2021-04-10",116,[695,15],"Obesity, Visceral",[673,697],"SCD gene variability in obesity and normal body weight patients.",{"intervention":697,"totalTrials":73,"cells":699},{"EARLY_PHASE1":700,"PHASE1":702,"PHASE2":704,"PHASE3":706,"PHASE4":708,"NA":710},{"trials":701,"activeCount":77},[],{"trials":703,"activeCount":77},[],{"trials":705,"activeCount":77},[],{"trials":707,"activeCount":77},[],{"trials":709,"activeCount":77},[],{"trials":711,"activeCount":77},[712],{"nctId":688,"briefTitle":689,"status":271,"phases":713,"primaryCompletion":691,"completion":691,"start":692,"enrollment":693,"conditions":714,"interventions":715},[],[695,15],[673,697],{"intervention":717,"totalTrials":73,"cells":718},"Hypertonic saline",{"EARLY_PHASE1":719,"PHASE1":721,"PHASE2":723,"PHASE3":725,"PHASE4":727,"NA":729},{"trials":720,"activeCount":77},[],{"trials":722,"activeCount":77},[],{"trials":724,"activeCount":77},[],{"trials":726,"activeCount":77},[],{"trials":728,"activeCount":77},[],{"trials":730,"activeCount":77},[731],{"nctId":732,"briefTitle":733,"status":358,"phases":734,"primaryCompletion":691,"completion":735,"start":736,"enrollment":737,"conditions":738,"interventions":740},"NCT03750136","Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic Syndrome",[70],"2023-03-01","2018-12-15",30,[739],"Nephrotic Syndrome",[717,741],"Furosemide",{"intervention":741,"totalTrials":73,"cells":743},{"EARLY_PHASE1":744,"PHASE1":746,"PHASE2":748,"PHASE3":750,"PHASE4":752,"NA":754},{"trials":745,"activeCount":77},[],{"trials":747,"activeCount":77},[],{"trials":749,"activeCount":77},[],{"trials":751,"activeCount":77},[],{"trials":753,"activeCount":77},[],{"trials":755,"activeCount":77},[756],{"nctId":732,"briefTitle":733,"status":358,"phases":757,"primaryCompletion":691,"completion":735,"start":736,"enrollment":737,"conditions":758,"interventions":759},[70],[739],[717,741],{"intervention":761,"totalTrials":73,"cells":762},"glutamine",{"EARLY_PHASE1":763,"PHASE1":765,"PHASE2":767,"PHASE3":769,"PHASE4":771,"NA":773},{"trials":764,"activeCount":77},[],{"trials":766,"activeCount":77},[],{"trials":768,"activeCount":77},[],{"trials":770,"activeCount":77},[],{"trials":772,"activeCount":77},[],{"trials":774,"activeCount":77},[775],{"nctId":776,"briefTitle":777,"status":358,"phases":778,"primaryCompletion":779,"completion":780,"start":781,"enrollment":782,"conditions":783,"interventions":785},"NCT01704664","Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients",[70],"2021-07","2022-10","2007-03",240,[784],"Gastric Cancer",[761,786],"Perioperative parenteral immunonutrition",{"intervention":786,"totalTrials":73,"cells":788},{"EARLY_PHASE1":789,"PHASE1":791,"PHASE2":793,"PHASE3":795,"PHASE4":797,"NA":799},{"trials":790,"activeCount":77},[],{"trials":792,"activeCount":77},[],{"trials":794,"activeCount":77},[],{"trials":796,"activeCount":77},[],{"trials":798,"activeCount":77},[],{"trials":800,"activeCount":77},[801],{"nctId":776,"briefTitle":777,"status":358,"phases":802,"primaryCompletion":779,"completion":780,"start":781,"enrollment":782,"conditions":803,"interventions":804},[70],[784],[761,786],{"intervention":806,"totalTrials":73,"cells":807},"5-Amino Levulinic Acid",{"EARLY_PHASE1":808,"PHASE1":810,"PHASE2":812,"PHASE3":814,"PHASE4":816,"NA":818},{"trials":809,"activeCount":77},[],{"trials":811,"activeCount":77},[],{"trials":813,"activeCount":77},[],{"trials":815,"activeCount":77},[],{"trials":817,"activeCount":77},[],{"trials":819,"activeCount":77},[820],{"nctId":821,"briefTitle":822,"status":271,"phases":823,"primaryCompletion":824,"completion":825,"start":826,"enrollment":6,"conditions":827,"interventions":829},"NCT07536737","Impact of PDT and Topical Corticosteroids on Taste Perception in Patients With OLP",[70],"2023-01-10","2023-07-10","2021-09-30",[828],"Oral Lichen Planus",[806,830],"Clobetasol Propionate 0.05% Cream",{"intervention":830,"totalTrials":73,"cells":832},{"EARLY_PHASE1":833,"PHASE1":835,"PHASE2":837,"PHASE3":839,"PHASE4":841,"NA":843},{"trials":834,"activeCount":77},[],{"trials":836,"activeCount":77},[],{"trials":838,"activeCount":77},[],{"trials":840,"activeCount":77},[],{"trials":842,"activeCount":77},[],{"trials":844,"activeCount":77},[845],{"nctId":821,"briefTitle":822,"status":271,"phases":846,"primaryCompletion":824,"completion":825,"start":826,"enrollment":6,"conditions":847,"interventions":848},[70],[828],[806,830]]